Memphasys Limited (ASX:MEM)

Australia · Delayed Price · Currency is AUD

0.0040

0.00 (0.00%)

At close: Nov 6, 2026

Market Cap	12.38M +38.1%
Revenue (ttm)	657.97K +24.9%
Net Income	-4.10M
EPS	-0.00
Shares Out	3.10B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	69,755
Open	0.0040
Previous Close	0.0040
Day's Range	0.0040 - 0.0040
52-Week Range	0.0030 - 0.0090
Beta	0.76
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About Memphasys

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, an in-vitro diagnostic device; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage product for... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2006

Employees 24

Stock Exchange Australian Securities Exchange

Ticker Symbol MEM

Full Company Profile

Financial Performance

In fiscal year 2026, Memphasys's revenue was 657,968, an increase of 24.87% compared to the previous year's 526,921. Losses were -4.10 million, -18.57% less than in 2025.

Financial Statements